{"database": "openregs", "table": "documents", "rows": [["FDA-2013-N-0500-0002", "FDA", "FDA-2013-N-0500", "OMB Review Proposed Rule re Executive Order 12866, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products 11-13-2013 - Memorandum", "Other", null, "2013-11-21T00:00:00Z", 2013, 11, null, null, "2013-11-25T14:34:53Z", null, 0, 1, "090000648148e9e1"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-N-0500-0002"], "units": {}, "query_ms": 51.0276909917593, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}